{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T22:31:17Z","timestamp":1788993077386,"version":"build-2803163510"},"reference-count":15,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1016\/j.ijantimicag.2009.12.019","type":"journal-article","created":{"date-parts":[[2010,2,26]],"date-time":"2010-02-26T10:36:51Z","timestamp":1267180611000},"page":"524-526","source":"Crossref","is-referenced-by-count":58,"title":["Thioridazine cures extensively drug-resistant tuberculosis (XDR-TB) and the need for global trials is now!"],"prefix":"10.1016","volume":"35","author":[{"given":"Leonard","family":"Amaral","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin J.","family":"Boeree","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen H.","family":"Gillespie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zarir F.","family":"Udwadia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dick","family":"van Soolingen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2009.12.019_bib1","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1136\/thx.2005.045963","article-title":"Risk factors for multidrug resistant tuberculosis in Europe: a systematic review","volume":"61","author":"Faustini","year":"2006","journal-title":"Thorax"},{"key":"10.1016\/j.ijantimicag.2009.12.019_bib2","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1056\/NEJM199302253280801","article-title":"The emergence of drug-resistant tuberculosis in New York City","volume":"328","author":"Frieden","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijantimicag.2009.12.019_bib3","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.3201\/eid0811.020288","article-title":"Molecular epidemiology of multidrug-resistant tuberculosis, New York City, 1995\u20131997","volume":"8","author":"Munsiff","year":"2002","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.ijantimicag.2009.12.019_bib4","unstructured":"World Health Organization. Anti-tuberculosis drug resistance in the world. Report No. 4. Geneva, Switzerland: WHO; 2008."},{"key":"10.1016\/j.ijantimicag.2009.12.019_bib5","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1089\/mdr.2008.0798","article-title":"Multidrug-resistant tuberculosis in Lisbon, Portugal: a molecular epidemiological perspective","volume":"14","author":"Perdig\u00e3o","year":"2008","journal-title":"Microb Drug Resist"},{"key":"10.1016\/j.ijantimicag.2009.12.019_bib6","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1378\/chest.08-2427","article-title":"Emergence of new forms of totally drug-resistant tuberculosis bacilli: super extensively drug-resistant tuberculosis or totally drug-resistant strains in Iran","volume":"136","author":"Velayati","year":"2009","journal-title":"Chest"},{"key":"10.1016\/j.ijantimicag.2009.12.019_bib7","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1093\/jac\/38.6.1049","article-title":"Inhibition of the respiration of multi-drug resistant clinical isolates of Mycobacterium tuberculosis by thioridazine: potential use for the initial therapy of freshly diagnosed tuberculosis","volume":"38","author":"Amaral","year":"1996","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2009.12.019_bib8","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1128\/AAC.47.3.917-922.2003","article-title":"Clinical concentrations of thioridazine kill intracellular multidrug-resistant Mycobacterium tuberculosis","volume":"47","author":"Ordway","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2009.12.019_bib9","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.ijantimicag.2008.10.028","article-title":"SILA 421, an inhibitor of efflux pumps of cancer cells, enhances the killing of intracellular extensively drug-resistant tuberculosis (XDR-TB)","volume":"33","author":"Martins","year":"2008","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2009.12.019_bib10","first-page":"771","article-title":"Amaral l. The curative activity of thioridazine on mice infected with Mycobacterium tuberculosis","volume":"21","author":"Martins","year":"2007","journal-title":"In Vivo"},{"key":"10.1016\/j.ijantimicag.2009.12.019_bib11","first-page":"19","article-title":"Tuberculosis extensamente resistente (XDR-TB) en Argentina: aspectos destacbles epidemiologicos, bacteriologicos, terapeuticos y evolutivos","volume":"1","author":"Abbate","year":"2007","journal-title":"Revista Argentina de Medicina Respiratoria"},{"key":"10.1016\/j.ijantimicag.2009.12.019_bib12","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1111\/j.1365-2125.2007.03021.x","article-title":"Thioridazine: resurrection as an antimicrobial agent?","volume":"64","author":"Thanacoody","year":"2007","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.ijantimicag.2009.12.019_bib13","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/j.1749-6632.2001.tb11365.x","article-title":"India's multidrug-resistant tuberculosis crisis","volume":"953","author":"Udwadia","year":"2001","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.ijantimicag.2009.12.019_bib14","doi-asserted-by":"crossref","first-page":"e292","DOI":"10.1371\/journal.pmed.0040292","article-title":"Randomized trials to optimize treatment of multidrug-resistant tuberculosis","volume":"4","author":"Mitnick","year":"2007","journal-title":"PLoS Med"},{"key":"10.1016\/j.ijantimicag.2009.12.019_bib15","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1093\/jac\/dkl260","article-title":"Clinical development of anti-tuberculosis drugs","volume":"58","author":"Mitchison","year":"2006","journal-title":"J Antimicrob Chemother"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092485791000021X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092485791000021X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,12]],"date-time":"2018-12-12T23:54:24Z","timestamp":1544658864000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092485791000021X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6]]},"references-count":15,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["S092485791000021X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2009.12.019","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2010,6]]}}}